The Effect of Laparoscopic Surgery on Ovarian Reserve According to Cyst Types
Primary Purpose
Ovarian Cysts
Status
Completed
Phase
Not Applicable
Locations
Turkey
Study Type
Interventional
Intervention
Laparoscopic cystectomy
Sponsored by

About this trial
This is an interventional treatment trial for Ovarian Cysts focused on measuring ovarian reserve, anti-mullerian hormone, ovarian cyst
Eligibility Criteria
Inclusion Criteria:
- no ovarian surgery before
Exclusion Criteria:
- Endocrinological pathologies
- Suspicion of malignancy in preoperative laboratory and ultrasonographic evaluations
- Detection of malignancy in histopathological examination
Sites / Locations
- Ege University Hospital
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Active Comparator
Active Comparator
Active Comparator
Arm Label
Endometrioma
Mature cystic teratoma (dermoid cyst)
Serous or mucinous cystadenoma
Arm Description
Participants who will have endometrioma after histopathological evaluation.
Participants who will have mature cystic teratoma (dermoid cyst) after histopathological evaluation.
Participants who will have serous or mucinous cystadenoma after histopathological evaluation.
Outcomes
Primary Outcome Measures
Change in AMH Level
AMH levels of the participants will be investigated before the surgery and 6 months after the surgery.
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT05054946
Brief Title
The Effect of Laparoscopic Surgery on Ovarian Reserve According to Cyst Types
Official Title
The Effect of Laparoscopic Surgery on Ovarian Reserve According to Cyst Types
Study Type
Interventional
2. Study Status
Record Verification Date
September 2022
Overall Recruitment Status
Completed
Study Start Date
October 1, 2021 (Actual)
Primary Completion Date
September 1, 2022 (Actual)
Study Completion Date
September 1, 2022 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Ege University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The aim of our study is to compare the effect of laparoscopic ovarian cystectomy on ovarian reserve in terms of different cyst types.
Detailed Description
Participants who will be treated surgically for ovarian cysts will be included in the study. Anti-Mullerian Hormone (AMH) levels of the participants will be investigated before the surgery and 6 months after the surgery. All surgeries will be performed under general anesthesia laparoscopically. After histopathological evaluation, the participants will be divided into three groups; Group 1: Endometrioma, Group 2: Mature cystic teratoma (Dermoid cyst) and Group 3: Serous or mucinous cystadenoma.
A total of fifty-five women will be included in the study.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Ovarian Cysts
Keywords
ovarian reserve, anti-mullerian hormone, ovarian cyst
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
55 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Endometrioma
Arm Type
Active Comparator
Arm Description
Participants who will have endometrioma after histopathological evaluation.
Arm Title
Mature cystic teratoma (dermoid cyst)
Arm Type
Active Comparator
Arm Description
Participants who will have mature cystic teratoma (dermoid cyst) after histopathological evaluation.
Arm Title
Serous or mucinous cystadenoma
Arm Type
Active Comparator
Arm Description
Participants who will have serous or mucinous cystadenoma after histopathological evaluation.
Intervention Type
Procedure
Intervention Name(s)
Laparoscopic cystectomy
Intervention Description
All surgeries will be performed under general anesthesia by laparoscopically.
Primary Outcome Measure Information:
Title
Change in AMH Level
Description
AMH levels of the participants will be investigated before the surgery and 6 months after the surgery.
Time Frame
6 months
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
no ovarian surgery before
Exclusion Criteria:
Endocrinological pathologies
Suspicion of malignancy in preoperative laboratory and ultrasonographic evaluations
Detection of malignancy in histopathological examination
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sabahattin Anil Ari, MD
Organizational Affiliation
Ege University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Ege University Hospital
City
İzmir
ZIP/Postal Code
35100
Country
Turkey
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
The Effect of Laparoscopic Surgery on Ovarian Reserve According to Cyst Types
We'll reach out to this number within 24 hrs